For citations:
Lisitsyna T.A., Borisova A.B., Reshetnyak T.M., Veltishchev D.Yu., Diatroptov M.E., Avdeeva A.S., Nurbaeva K.S., Abramkin A.A., Nasonov E.L. Clinical significance of the determination of antibodies to the NR2 subunit of glutamate N-methyl-D-aspartate receptors (aNMDAR) in patients with systemic lupus erythematosus and antiphospholipid syndrome. Rheumatology Science and Practice. 2025;63(2):168-175. (In Russ.) https://doi.org/10.47360/1995-4484-2025-168-175
Email this article 